KPJ upgraded to buy, value emerges

With Maybank IB Research’s latest call upgrade, a total of 13 out of 18 analysts recommended a “buy” on KPJ, according to Bloomberg data.

PETALING JAYA: Maybank IB Research is the second research house over the last five months to upgrade its recommendation on KPJ Healthcare Bhd to “buy”, as it believes the stock’s selling is overdone and new value is expected to emerge.

The research house has forecast KPJ to record stronger results in the third quarter of financial year 2019 (3Q19), exceeding the RM43.4mil core net profit registered in 2Q19.